08.30 – 08.45 h Welcome
Bart De Wever, ALTEXA Development, Monaco
IVTIP Board/Executive Secretary
08.45 – 09.30 h Quality assessment of toxicity studies on nanomaterials
Jeffrey W. Card, Senior Program Manager, Toxicology Intertek Cantox, Ontario, Canada
09.30 – 10.15 h Nanomaterial measurement: the role of standardization and harmonization
Christoph Klein, Program Manager
Institute for Reference Materials and Measurements
JRC, European Commission, Belgium
10.15 – 10.45 h Coffee Break
10.45 – 11.30 h Experimental nanotoxicity testing in vivo and in vitro
Frieke Kuper, Senior Scientist Quality of Life
TNO, The Netherlands
11.30 – 12.15 h Regulatory issues and nanomaterial riks
Steffi Friedrich, Director General
The Nanotechnology Industry Association, Belgium
12.15 - 13.30 h Lunch
13.30 – 14.15 h In vitro models of biological barriers for safety and efficacy testing of
nanomedicines
Claus-Michael Lehr, Head, Department of Drug Delivery
Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Germany
14.15 – 15.00 h The in vivo fate of nanomedicines and nanotoxicity
Elias Fattal, Director UMR CNRS 8612.
Univ. Of Paris Sud, School of Pharmacy, France
15.00 – 15.30 h Coffee Break
15.30 – 16.10 h Advances and challenges when investigating toxicological responses to
inhaled nanoparticles at the in vitro level
Tobias Stoeger, Head Institute of Inhalation Biology
Helmholtz Zentrum München, Germany
16.10 – 16.30 h Human skin organ culture as a potential non animal model for safety
evaluation of metallic nanoparticles
Myriam Oron, R&D Manager of Clineral, Chemist of the Medical Division
AHAVA Dead Sea Laboratories, Israel
16.30 – 16.50 h New advances in the toxicological evaluation of nanomaterials
Blanca Suarez, Head of Biomedicine Unit
Gaiker Technology Center, Spain
16.50 – 17.35 h Presentation of 3 selected posters
17.35 – 18.00 h Round Table Round up
Parque Tecnológico, Ed. 202